Professional Documents
Culture Documents
MAYAGUEZ PR
MEDICATION
CARD HOLDER
Introducción a Farmacología
INDEX
PAGE
INTRODUCTION -1-
BRONCHODILATORS -2-3-
MUCOLYTICS -7-
CONCLUSION -8-
REFERECES -9-
INTRODUCTION
Medications related to the respiratory system are intended to increase the caliber of the
respiratory tract to achieve an increase in air flow in the airway, promote gas exchange
and reduce respiratory effort.
Next, we will be getting to know some of these drugs. Among the classifications of
Bronchodilators, Inhaled Corticosteroids, Nonsteroidal Antiasthma Medications, and
Mucolytics.
We will describe each drug with its generic and commercial name, availability, dose
range, adverse effects, contraindications, and cautions.
-1-
BRONCODILATORS
-3-
INHALED CORTICOSTEROIDS
Inhaled Corticosteroids - Act directly in the lungs to inhibit the inflammatory
process that causes asthma.
NAME AVAILABILITY DOSAGE ADVERSE CONTRAINDICATIONS
RANGE EFFECTS & CAUTIONS
Budesonide DPI: (Flexhaler): DPI: (Flexhaler): Headache, ● Contraindicated with
(Pulmicort 90,180 mcg/ 180– nausea, hypersensitivity to drug or for relief
Flexhaler, inhalation DPI: 720 mcg 2 respiratory of acute asthma or bronchospasm.
Pulmicort (Turbuhaler): times/day infection, rhinitis
DPI: (Turbuhaler):
Respules) 200 mcg/ 400– ● Use cautiously with TB, systemic
inhalation NEB: 2,400 mcg/ day infections, lactation.
(Respules): 0.25, in 2–4 divided
0.5 mg/2 m doses NEB: Oral
(Respules): ● Contraindicated with
250–500 hypersensitivity to drug,
mcg 1–2 lactation.
times/day or 1 ● Use cautiously with TB,
mg once daily hypertension, diabetes mellitus,
osteoporosis, peptic ulcer disease,
glaucoma, cataracts, family history
of diabetes or glaucoma, other
conditions in which
glucocorticosteroids may have
unwanted effects.
Nasal
● Contraindicatedwith
hypersensitivity to drug, nasal
infections, nasal trauma, nasal
septal ulcers, and recent nasal
surgery.
Beclomethasone MDI: 40, 80 MDI: 40–320 mcg Cough, ● Respiratory inhalant therapy:
(Qvar)
mcg/inhalation 2 hoarseness, Contraindicated with acute
times/day headache, asthmatic attack, status
pharyngitis asthmaticus. Use caution with
systemic fungal infections (may
cause exacerbations), allergy to any
ingredient, status asthmaticus,
lactation.
● Intranasal therapy:
Use caution with untreated local
infections (may cause
exacerbations), nasal septal ulcers,
recurrent epistaxis, nasal surgery
or trauma (interferes with
healing); lactation.
-4-
NONSTEROIDAL ANTIASTHMA MEDICATIONS
Nonsteroidal Antiasthma Medications -Are used for the prophylactic management of
asthma. They are not to be administered during an acute asthma attack because they do
not provide immediate relief.
NAME AVAILABILITY DOSAGE RANGE ADVERSE CONTRAINDICATIONS &
EFFECTS CAUTIONS
Montelukast T: 4 mg, 5 mg, 10 A: 10 mg/day Dyspepsia, ● Contraindicated with
(Singulair) mg increased LFTs, hypersensitivity to
C: (6–14 yrs): 5 cough, nasal montelukast or any of its
mg/day congestion, components; acute asthma
headache, attacks; status asthmaticus.
C: (2–5 yrs): 4 dizziness,
mg/day fatigue ● Use cautiously with
pregnancy and lactation.
-5-
INHALED ANTIIFECTIVE AGENTS
Inhaled anti-infective agents - Inhaled anti-infective are agents that act locally, in the lungs to treat
infection. Inhaled antibiotics are used to treat bacterial infection and antiviral medicines treat viral
infections.
NAME AVAILABILITY DOSAGE ADVERSE CONTRAINDICATIONS
RANGE EFFECTS & CAUTIONS
tobramycin Inhalation ADULTS, Hypotension, ● Contraindicated with
(TOBI, Tobrex) Powder: (TOBI CHILDREN nausea, vomiting hypersensitivity to
Podhaler): 28 mg 6 YRS AND aminoglycosides;
in a capsule. OLDER: 300 mg pregnancy, lactation.
Nebulization: q12h ● Use cautiously with
(TOBI): 60 mg/ 28 days on, 28 patients who are elderly
mL. days off. or who have diminished
(Tobi Podhaler): hearing, decreased
Four 28-mg renal function,
capsules twice dehydration,
daily for 28 days neuromuscular
followed by 28 disorders (myasthenia
days gravis, parkinsonism,
off. infant botulism), herpes,
vaccinia, varicella,
mycobacterial infections,
fungal infections.
zanamivir Powder for ADULTS, Diarrhea, sinusitis, ● Contraindicated with
zan-am-i-veer Inhalation: 5 ELDERLY, nausea, bronchitis, allergy to any component
(Relenza Diskhaler) mg/blister. CHILDREN cough, of the drug.
7 YRS AND dizziness, headache. ● Use cautiously with
OLDER: 2 pregnancy, lactation,
inhalations (one asthma,
5-mg blister per COPD, or severe medical
inhalation for conditions.
total dose
of 10 mg) twice
daily
(approximately
12
hrs apart) for 5
days.
-6-
MUCOLYTICS
Mucolytics - Are used to increase the output of bronchial secretions, enhance the clearance of
bronchial exudate, and promote a productive cough.
NAME AVAILABILITY DOSAGE ADVERSE CONTRAINDICATIONS &
RANGE EFFECTS CAUTIONS
N-acetylcysteine Solution: 10%, SVN: 3–5 mL Nausea, ● Contraindicated with
10% 20% stomatitis hypersensitivity to
N-
Bronchospasm, acetylcysteine; use caution
acetylcysteine
Rhinorrhea and discontinue
20%
immediately if
(Mucomyst)
Antidotal use bronchospasm occurs.
Rash Nausea,
vomiting, Antidotal use
● Use caution with
Anaphylactoid esophageal varices, peptic
reactions ulcer.
Dornase Solution : 1mg, SVN: 2.5 chest pain No contraindications other
alfa 1mL mg/ampule, (pleuritic), pyrexia, than hamster protein
(Pulmozy 1 ampule conjunctivitis, hypersensitivity or
me) qd dyspepsia, hypersensitivity to the
dysphonia, product or its ingredients
pharyngitis, are known.
dyspnea, laryngitis,
rhinitis, decreased Cautions Dornase alfa
lung function, rash, should be used only with
urticaria other standard treatments
for cystic fibrosis
-7-
CONCLUSION
Breathing correctly restores us to physical health, revitalizes the body, increases mental
capacity and harmony, and reduces the possibility of getting sick.
We conclude this work, recognizing the importance of fully knowing each one of the
medications that we will administer to our patients, by taking care of the management of
the patient's airway from the onset of the disease. We as Respiratory Therapists are an
essential part of the team of health professionals in charge of restoring respiratory health
to our patients.
-8-
REFERENCES
References:
Karch, A. M. (2013). Lippincott’s Nursing Drug Guide 2014 (1.a ed.). Lippincott
Williams & Wilkins. Kizior, R. J., & Hodgson, K. (2020). Saunders Nursing
Drug Handbook 2021 (1.a ed.). Saunders.
Staff, P., & Reference, P. D. (2014). 2015 Physicians’ Desk Reference, 69th Edition
(69th 2015 ed.). PDR Network.
-10-